Glenview Capital Management 13F, Q1 2025
Larry Robbins · quarter ending 31 March 2025 · filed 15 May 2025 · SEC CIK 1138995
Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 1 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.
Largest positions, Q1 2025
The 25 largest of 44 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2024 filing.
| Company | Ticker | Value | % of book | vs Q4 2024 |
|---|---|---|---|---|
| CVS HEALTH CORP | CVS | $809.40M | 20.0% | unchanged |
| TENET HEALTHCARE CORP | THC | $456.61M | 11.3% | +20% shares |
| GLOBAL PMTS INC | GPN | $371.48M | 9.2% | -3% shares |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | $227.15M | 5.6% | +75% shares |
| ALIGHT INC | ALITEUR | $193.97M | 4.8% | +3% shares |
| UNIVERSAL HLTH SVCS INC | UHS | $166.74M | 4.1% | unchanged |
| AMAZON COM INC | AMZN | $141.36M | 3.5% | +123% shares |
| ZOOMINFO TECHNOLOGIES INC | GTM | $127.87M | 3.2% | +28% shares |
| THE CIGNA GROUP | CI | $123.06M | 3.0% | -41% shares |
| DXC TECHNOLOGY CO | DXC | $118.65M | 2.9% | -12% shares |
| US FOODS HLDG CORP | USFD | $116.89M | 2.9% | +11% shares |
| EXPEDIA GROUP INC | EXPE | $108.92M | 2.7% | -26% shares |
| CORTEVA INC | CTVA | $87.61M | 2.2% | -32% shares |
| DUN & BRADSTREET HLDGS INC | $87.33M | 2.2% | -34% shares | |
| AVIS BUDGET GROUP | CAR | $83.71M | 2.1% | +70% shares |
| PAYPAL HLDGS INC | PYPL | $79.39M | 2.0% | new |
| CENTENE CORP DEL | CNC | $79.02M | 1.9% | unchanged |
| VIATRIS INC | VTRS | $73.97M | 1.8% | -9% shares |
| KNIGHT-SWIFT TRANSN HLDGS IN | KNX | $61.06M | 1.5% | +17% shares |
| ELEMENT SOLUTIONS INC | ESI | $57.25M | 1.4% | +3% shares |
| MCKESSON CORP | MCK | $55.09M | 1.4% | -46% shares |
| BRUNSWICK CORP | BC | $39.40M | 1.0% | +68% shares |
| DISNEY WALT CO | DIS | $36.29M | 0.9% | new |
| MYRIAD GENETICS INC | MYGN | $34.59M | 0.8% | -6% shares |
| PINTEREST INC | PINS | $32.97M | 0.8% | +197% shares |
What changed since Q4 2024
Against the Q4 2024 filing, Glenview Capital Management opened 13 new positions, added to 12, trimmed 12, left 7 unchanged and exited 5. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0000905148-25-001735, filed by GLENVIEW CAPITAL MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.